Bank Of Montreal Tg Therapeutics, Inc. Put Options Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 01, 2023	BUY	$5.01 - $11.83 $1,002 - $2,366	200 Added 0.24%	83,100 $983,000
Q1 2022 May 12, 2022	BUY	$7.81 - $20.45 $42,955 - $112,475	5,500 Added 7.11%	82,900 $816,000
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $1.69 Million - $3.13 Million	77,400 New	77,400 $2.61 Million

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.